Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. [electronic resource]
Producer: 20090107Description: 483-6 p. digitalISSN:- 0949-2321
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cyclophosphamide -- adverse effects
- Diagnosis, Differential
- Fatal Outcome
- Hepatitis B, Chronic -- complications
- Humans
- Liver -- pathology
- Liver Failure, Acute -- etiology
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Recurrence
- Rituximab
- Vidarabine -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.